Y Kodera, 2002, J Am Coll Surg, 195, 855, 10.1016/S1072-7515(02)01496-5
JJ Bonenkamp, 1999, N Engl J Med, 340, 908, 10.1056/NEJM199903253401202
SA Hundahl, 2002, Ann Surg Oncol, 9, 278, 10.1007/BF02573066
JJ Bonenkamp, 1998, Gastric Cancer, 1, 152, 10.1007/s101200050010
KC Peeters, 2005, World J Surg, 29, 1576, 10.1007/s00268-005-7907-9
SA Hundahl, 2007, Gastric Cancer, 10, 84, 10.1007/s10120-007-0426-7
CW Wu, 2006, Lancet Oncol, 7, 309, 10.1016/S1470-2045(06)70623-4
CW Wu, 2005, Eur J Surg Oncol, 31, 153, 10.1016/j.ejso.2004.09.018
T Sano, 2004, J Clin Oncol, 22, 2759, 10.1200/JCO.2004.10.184
K Droste, 1996, Cancer Lett, 109, 141, 10.1016/S0304-3835(96)04438-2
A Cuschieri, 1999, Br J Cancer, 79, 1522, 10.1038/sj.bjc.6690243
Y Sakata, 1998, Eur J Cancer, 34, 1715, 10.1016/S0959-8049(98)00211-1
T Nakajima, 1999, Lancet, 354, 273, 10.1016/S0140-6736(99)01048-X
A Nashimoto, 2003, J Clin Oncol, 21, 2282, 10.1200/JCO.2003.06.103
Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, Nakajima T, et al. No survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer: randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer — Japan Clinical Oncology Group 9206–2. In: Proceedings of the Gastointestinal Cancers Symposium, 2004
JS Macdonald, 2001, N Engl J Med, 345, 723, 10.1056/NEJMoa010187
D Cunningham, 2006, N Engl J Med, 355, 11, 10.1056/NEJMoa055531
H Imanaga, 1977, World J Surg, 2, 213, 10.1007/BF01665086
W Koizumi, 2003, Br J Cancer, 89, 2207, 10.1038/sj.bjc.6601413
K Yoshida, 2006, Clin Cancer Res, 12, 3402, 10.1158/1078-0432.CCR-05-2425
R Simon, 2006, Nat Clin Pract Oncol, 3, 406, 10.1038/ncponc0560
M Kobayashi, 2006, Gastric Cancer, 9, 114, 10.1007/s10120-006-0364-9
A Tsuburaya, 2005, Jpn J Clin Oncol, 35, 672, 10.1093/jjco/hyi179
S Kim, 2005, Int J Radiat Oncol Biol Phys, 63, 1279, 10.1016/j.ijrobp.2005.05.005
